Reston, VA, United States of America

Michael Myers



Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Myers: Innovator in Controlled Release Compositions

Introduction

Michael Myers is a notable inventor based in Reston, Virginia. He holds a patent for a significant innovation in the field of pharmaceutical compositions. His work focuses on improving the treatment of lipid levels in patients, showcasing his commitment to advancing medical science.

Latest Patents

Myers' patent, titled "Controlled release compositions and methods for the treatment of lipid lowering dosage units," introduces a once-daily dosage form that minimizes side effects. This innovative composition combines microspheres designed to co-deliver both an HMG-CoA reductase inhibitor and a niacin component. This dual approach aims to enhance the efficacy of lipid-lowering treatments while ensuring patient comfort.

Career Highlights

Throughout his career, Michael Myers has made significant contributions to the pharmaceutical industry. He has worked with reputable companies such as Fuisz International Ltd. and Biovail Laboratories International S.r.l. His experience in these organizations has allowed him to refine his expertise in drug formulation and delivery systems.

Collaborations

Myers has collaborated with various professionals in the field, including Pradeepkumar P Sanghvi. These partnerships have facilitated the exchange of ideas and innovations, further enhancing the development of effective pharmaceutical solutions.

Conclusion

Michael Myers is a distinguished inventor whose work in controlled release compositions has the potential to transform lipid-lowering treatments. His dedication to innovation and collaboration underscores the importance of advancing medical therapies for better patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…